We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$14.5B
AUM Growth
+$44.4M
Cap. Flow
-$380M
Cap. Flow %
-2.62%
Top 10 Hldgs %
8.38%
Holding
1,266
New
53
Increased
458
Reduced
387
Closed
91

Sector Composition

Rank Sector Weight
1 Industrials 28.7%
2 Technology 16.88%
3 Consumer Discretionary 12.48%
4 Financials 12.41%
5 Materials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTUS
1126
DELISTED
Natus Medical Inc
NTUS
$27K ﹤0.01%
744
+278
+60% +$9.81K
AROW icon
1127
Arrow Financial
AROW
$662M
$26K ﹤0.01%
816
+282
+53% +$9.16K
PRGS icon
1128
Progress Software
PRGS
$1.75B
$26K ﹤0.01%
749
+268
+56% +$10.6K
VSEC icon
1129
VSE Corp
VSEC
$5.19B
$26K ﹤0.01%
784
+438
+127% +$17.9K
XOXO
1130
DELISTED
Xo Group Inc
XOXO
$26K ﹤0.01%
749
+362
+94% +$11.2K
HIBB
1131
DELISTED
Hibbett, Inc. Common Stock
HIBB
$26K ﹤0.01%
1,395
+642
+85% +$14.5K
APEI icon
1132
American Public Education
APEI
$940M
$25K ﹤0.01%
+769
New +$29.4K
LEE icon
1133
Lee Enterprises
LEE
$175M
$25K ﹤0.01%
+942
New +$27.7K
VHI icon
1134
Valhi
VHI
$389M
$25K ﹤0.01%
+905
New +$45.5K
PENG
1135
Penguin Solutions Inc
PENG
$2.24B
$25K ﹤0.01%
1,752
+1,082
+161% +$16.9K
CSS
1136
DELISTED
CSS Industries, Inc.
CSS
$25K ﹤0.01%
1,762
+843
+92% +$12.7K
NIC icon
1137
Nicolet Bankshares
NIC
$3.6B
$24K ﹤0.01%
433
+178
+70% +$9.85K
ADUS icon
1138
Addus HomeCare
ADUS
$2.22B
$23K ﹤0.01%
+330
New +$21.4K
ANIK icon
1139
Anika Therapeutics
ANIK
$215M
$23K ﹤0.01%
539
+225
+72% +$8.89K
ANIP icon
1140
ANI Pharmaceuticals
ANIP
$1.86B
$23K ﹤0.01%
+404
New +$24.7K
CORT icon
1141
Corcept Therapeutics
CORT
$9.98B
$23K ﹤0.01%
1,618
+871
+117% +$12.2K
DHX icon
1142
DHI Group
DHX
$177M
$23K ﹤0.01%
10,767
+5,741
+114% +$12.1K
EPM icon
1143
Evolution Petroleum
EPM
$133M
$23K ﹤0.01%
2,070
+855
+70% +$9.01K
NVEC icon
1144
NVE Corp
NVEC
$543M
$23K ﹤0.01%
215
+88
+69% +$10.1K
QDEL icon
1145
QuidelOrtho
QDEL
$1.13B
$23K ﹤0.01%
354
+141
+66% +$9.86K
ARQ icon
1146
Arq
ARQ
$83.3M
$23K ﹤0.01%
+1,894
New +$21.6K
ENTA icon
1147
Enanta Pharmaceuticals
ENTA
$362M
$22K ﹤0.01%
263
+141
+116% +$14.1K
ARC
1148
DELISTED
ARC Document Solutions, Inc.
ARC
$22K ﹤0.01%
+7,660
New +$21K
INBK icon
1149
First Internet Bancorp
INBK
$233M
$21K ﹤0.01%
701
+342
+95% +$10.9K
CNCE
1150
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$21K ﹤0.01%
1,425
+758
+114% +$11.9K

Similar funds

Royce & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Royce & Associates held 1,266 positions worth $14.5B, up 0.31% from $14.5B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Royce & Associates's Q3 2018 filing shows 53 new, 458 increased, 387 reduced and 91 closed positions. Its largest new stake was Perspecta Inc. Common Stock: 664,450 shares worth $17.1M. The largest sale was Capella Education Company, an estimated $72M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q3 2018 buy was Perspecta Inc. Common Stock: 664,450 shares worth $17.1M.
  • Royce & Associates added most to Strategic Education in Q3 2018, an estimated $59M increase.
  • Royce & Associates's biggest Q3 2018 reduction was Copart, cutting an estimated $51.2M.
  • Royce & Associates fully exited Capella Education Company in Q3 2018, selling an estimated $72M.
  • Royce & Associates's ten largest holdings make up 8.4% of its $14.5B portfolio in Q3 2018.
  • Royce & Associates opened 53 new positions and closed 91 in Q3 2018.
  • Royce & Associates's portfolio value rose 0.31% quarter-over-quarter to $14.5B.

Based on Royce & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.